08/14/2025
4:55 PM | Tenax Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
08/14/2025
9:47 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/13/2025
3:22 PM | Tenax Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/03/2025
7:08 AM | Hunter Robyn (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
7:11 AM | PROEHL GERALD T (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
7:12 AM | Doogan Declan (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
7:13 AM | Davidson Michael H. (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
7:14 AM | Almenoff June Sherie (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
3:34 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/17/2025
3:30 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
5:50 PM | Giordano Christopher Thomas (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TENX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/20/2025
5:54 PM | Rich Stuart (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
4:44 PM | Tenax Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
7:34 AM | RTW INVESTMENTS, LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/14/2025
11:50 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/25/2025
6:42 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
6:45 AM | Tenax Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
6:47 AM | Tenax Therapeutics (Filer)
| Form ARS | |
04/23/2025
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
04/23/2025
3:10 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
04/15/2025
4:24 PM | Tenax Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/09/2025
3:06 PM | Tenax Therapeutics (Filer)
| Form PRE 14A | |
04/04/2025
3:53 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/12/2025
4:26 PM | Dellora Investments LP (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
4:00 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
11:37 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/15/2025
3:14 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
3:27 PM | Dellora Investments LP (Reporting)
Tenax Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/12/2024
7:02 PM | Giordano Christopher Thomas (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:04 PM | Hunter Robyn (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:07 PM | PROEHL GERALD T (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:09 PM | Rich Stuart (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:49 PM | Almenoff June Sherie (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:54 PM | Davidson Michael H. (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:58 PM | Doogan Declan (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:54 PM | MCGAULEY THOMAS (Reporting)
Tenax Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/05/2024
12:47 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G | |
11/26/2024
3:30 PM | Tenax Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/14/2024
6:14 PM | Lind Global Fund II LP (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
11:39 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:21 AM | CVI Investments, Inc. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
11/13/2024
4:35 PM | Stonepine Capital Management, LLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
7:15 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
10/30/2024
3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
7:14 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
09/12/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
09/12/2024
3:15 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
09/10/2024
4:19 PM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/30/2024
3:19 PM | Tenax Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/30/2024
3:20 PM | Tenax Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/23/2024
3:31 PM | Tenax Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/19/2024
5:48 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/15/2024
3:19 PM | Stonepine Capital Management, LLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
MarketBeat All Access